806 Applications Approved so Far Under PLI Schemes: Govt in Lok Sabha
7 Articles
7 Articles
India Moves to Curb Cheap Pharma Imports, Boosts ‘Make in India’ Push
In a strategic move to protect and promote domestic pharmaceutical manufacturing, the Indian government is considering introducing a Minimum Import Price (MIP) on key pharma raw materials. The goal is to shield domestic producers benefiting from the ₹15,000 crore Production-Linked Incentive (PLI) scheme for bulk drugs. According to sources, discussions are underway between the Department of Pharmaceuticals, the Prime Minister’s Office, and minis…
48 Pharma Projects Approved Under PLI Scheme - SMEVENTURE
India’s pharmaceutical sector is seeing significant progress under the Production Linked Incentive (PLI) Scheme for Key Starting Materials (KSMs), Drug Intermediates (DIs), and Active Pharmaceutical Ingredients (APIs). A total of 48 projects have been approved to strengthen local manufacturing of critical components, many of which were previously dependent on imports. The initiative is aimed at reducing supply chain vulnerabilities, particularly…
Govt provides update on schemes implemented in the pharma sector - Express Pharma
Number of schemes are being implemented to realise the vision of Atmanirbhar Bharat in the pharmaceutical sector and to support domestic innovation and reduce reliance on pharmaceutical imports, including the following: Promotion of Research and Innovation in Pharma MedTech Sector (PRIP) scheme; Production Linked Incentive (PLI) Scheme for Pharmaceuticals; PLI Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KS…
806 applications approved so far under PLI schemes: Govt in Lok Sabha
New Delhi: The government on Tuesday said as many as 806 applications have been approved under the Production Linked Incentive (PLI) schemes across 14 sectors as on date. The schemes for 14 key sectors including telecom, electronics, pharma, textiles and auto were announced with an outlay of Rs 1.97 lakh crore to enhance India’s manufacturing capabilities and exports. It was announced in 2021. “As on date, 806 applications have been approved und…
Manufacturing: 48 KSM-DI-API projects approved
Rs.4,254cr invested in manufacturing drugs Forty-eight projects have been approved under the Production Linked Incentive (PLI) Scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs) / Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India. The scheme aims to avoid disruption in supply of critical active pharmaceutical ingredients (APIs) used to […] Source
48 projects approved to avoid disruption in supply of critical active pharma ingredients - tennews.in: National News Portal
New Delhi, July 22 (IANS) The government on Tuesday said that it has approved 48 projects under the production-linked incentive (PLI) scheme for promotion of domestic manufacturing of critical Key Starting Materials (KSMs) /Drug Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India. The scheme aims to avoid disruption in supply of critical active pharmaceutical […] The post 48 projects approved to avoid disruption in supply o…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium